×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
[Session 2] Safety Pharmacology Electrophysiology - Insights from the CiPA, JiCSA and iSmart Initiatives
Session Chair(s)
Kentaro Ando, PhD
Department of Pharmacology
Toho University Faculty of Medicine, Japan
Yasunari Kanda, PhD
Head of Division of Pharmacology
National Institute of Health Sciences, Japan
Speaker(s)
US FDA CiPA Paradigm Overview
David Strauss, MD, PhD
FDA, United States
Director, Division of Applied Regulatory Science, OCP, OTS, CDER
JiCSA Overview/Update
Kohei Sawada
Eisai Co., Ltd., Japan
Head of Global Cardiovascular Assessment
iSmart Update
Keiichi Asakura, PhD
Nippon Shinyaku Co., Ltd., Japan
Senior Scientist, Pharmacokinetics and Safety Assessment Department
Electrophysiological Properties of Human iPS-Derived Cardiomyocytes
Junko Kurokawa, PhD
Tokyo Medical and Dental University, Japan
Associate Professor, Medical Research Institute, Advanced Molecular Medicine,
Have an account?